Formulation Development

Statistics Required in Formulation Development

Chief Pharmacist

1. Formulation development is not trial and error. 2. The purpose of statistics in pharmaceutical R and D is not ...

API Particle Size Distribution (PSD) Matters in Generic Formulations

Chief Pharmacist

In generic oral solid dosage forms, API particle size distribution is not just a physical parameter—it is a critical material ...

Lean Six Sigma and QbD

Chief Pharmacist

Quality by Design (QbD) is a science- and risk-based approach outlined in ICH Q8, Q9, and Q10. It emphasizes that ...

Relationship Between QTPP and CQA

Chief Pharmacist

Introduction In QbD) the development of a pharmaceutical product starts with understanding the patient and therapeutic needs. These needs are ...

Quality Target Product Profile (QTPP) in Pharmaceutical Development

Chief Pharmacist

The Quality Target Product Profile (QTPP) is a prospective summary of the key quality characteristics that a drug product should ...

Lean Six Sigma in Pharmaceutical Formulation Development – A Practical Perspective

Chief Pharmacist

In today’s competitive pharmaceutical environment, cost optimization, regulatory compliance, and speed to market are critical success factors. While Quality by ...